scholarly article | Q13442814 |
P50 | author | Steven Rosenberg | Q2347448 |
P2093 | author name string | Jacobs C | |
Coleman CN | |||
Horning SJ | |||
Lewis BJ | |||
Tseng A Jr | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | etoposide | Q418817 |
P304 | page(s) | 475-478 | |
P577 | publication date | 1987-05-01 | |
P1433 | published in | Cancer Treatment Reports | Q27710285 |
P1476 | title | Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate | |
P478 | volume | 71 |
Q45289991 | An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU. |
Q33493801 | EPIC: an effective low toxicity regimen for relapsing lymphoma |
Q40694333 | Etoposide: current status and future perspectives in the management of malignant neoplasms |
Q54242190 | High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease. |